Advantage Alpha Capital Partners LP Ironwood Pharmaceuticals Inc Transaction History

Advantage Alpha Capital Partners LP

  • $419 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$5.58 - $8.61 $69,482 - $107,211
-12,452 Reduced 9.51%
118,514 $772,000
Q1 2024

May 13, 2024
BUY
$8.32 - $15.45 $43,771 - $81,282
5,261 Added 4.19%
130,966 $1.14 Million
Q4 2023

Feb 13, 2024
BUY
$8.79 - $11.51 $1.1 Million - $1.45 Million
125,705 New
125,705 $1.44 Million

Others Institutions Holding IRWD

# of Institutions
231
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $570M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email